These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 11929828)

  • 41. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
    Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
    Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression.
    Del Sal G; Murphy M; Ruaro E; Lazarevic D; Levine AJ; Schneider C
    Oncogene; 1996 Jan; 12(1):177-85. PubMed ID: 8552389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
    Le NT; Richardson DR
    Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of cyclin D1 inhibits TNF-induced growth arrest.
    Moneo V; del Valle Guijarro M; Link W; Carnero A
    J Cell Biochem; 2003 Jun; 89(3):484-99. PubMed ID: 12761882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.
    Yang WC; Mathew J; Velcich A; Edelmann W; Kucherlapati R; Lipkin M; Yang K; Augenlicht LH
    Cancer Res; 2001 Jan; 61(2):565-9. PubMed ID: 11212250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development.
    Rodriguez-Puebla ML; Robles AI; Conti CJ
    Mol Carcinog; 1999 Jan; 24(1):1-6. PubMed ID: 10029404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
    Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of p21 (WAF-1/CIP1) during differentiation.
    Steinman RA; Hoffman B; Iro A; Guillouf C; Liebermann DA; el-Houseini ME
    Oncogene; 1994 Nov; 9(11):3389-96. PubMed ID: 7936667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors.
    Bearss DJ; Subler MA; Hundley JE; Troyer DA; Salinas RA; Windle JJ
    Oncogene; 2000 Feb; 19(8):1114-22. PubMed ID: 10713698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in cell cycle regulation in mouse skin tumors.
    Balasubramanian S; Ahmad N; Jeedigunta S; Mukhtar H
    Biochem Biophys Res Commun; 1998 Feb; 243(3):744-8. PubMed ID: 9500999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclin D1 overexpression in mouse epidermis increases cyclin-dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development.
    Rodriguez-Puebla ML; LaCava M; Conti CJ
    Cell Growth Differ; 1999 Jul; 10(7):467-72. PubMed ID: 10437914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.